Evidence map›Paper›PMID 40163804›Full record

ArticleBlood2025

Iron overload in HFE-related hemochromatosis severely impairs Vδ2+ γδ T-cell homeostasis.

Derya Erdogdu, Ina Becoku, Valerie Huber, Yao Wang, Matthias Eyrich, Hisayoshi Hashimoto, Michaela Döring, Johannes Schulte, Karin Schilbach

Abstract read
In one paragraph

Article in Blood, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Derya ErdogduDepartment of Pediatric Hematology and Oncology, University Children's Hospital Tuebingen, Tübingen, Germany.ORCID 0000-0002-9413-0812
Ina BecokuDepartment of Pediatric Hematology and Oncology, University Children's Hospital Tuebingen, Tübingen, Germany.
Valerie HuberDepartment of Pediatric Hematology and Oncology, University Children's Hospital Tuebingen, Tübingen, Germany.
Yao WangDepartment of Pediatric Hematology and Oncology, University Children's Hospital Tuebingen, Tübingen, Germany.
Matthias EyrichDepartment of Pediatric Hematology, Oncology and Stem Cell Transplantation, University Children's Hospital, University Hospital Würzburg, Würzburg, Germany.ORCID 0000-0002-8099-5903
Hisayoshi HashimotoDepartment of Pediatric Hematology and Oncology, University Children's Hospital Tuebingen, Tübingen, Germany.ORCID 0000-0002-3691-4416
Michaela DöringDepartment of Pediatric Hematology and Oncology, University Children's Hospital Tuebingen, Tübingen, Germany.
Johannes SchulteDepartment of Pediatric Hematology and Oncology, University Children's Hospital Tuebingen, Tübingen, Germany.ORCID 0000-0003-0671-1201
Karin SchilbachDepartment of Pediatric Hematology and Oncology, University Children's Hospital Tuebingen, Tübingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractHFE-related hemochromatosis induces systemic iron overload. Although extensive studies indicate a pivotal role for iron homeostasis in αβ T-cell immunity, its effect on γδ T cells is unknown. Here, we found a reversal of the Vδ2+/Vδ2- ratio in the γδ T-cell compartment as a feature of hemochromatosis, which is associated with a Vδ2+ population that cannot be enriched by zoledronic acid (ZOL) stimulation, despite evidence of T-cell receptor (TCR)-ligand formation and strong proliferative behavior. In vivo, reactive oxygen species (ROS) production and exhaustion marker expression are significantly increased on Vδ2+ T cells in hemochromatosis compared with healthy individuals. Ex vivo, hemochromatosis donor-derived Vδ2+ cells are hyporesponsive to TCR stimulation in terms of ROS production but significantly increase their paramount expression of exhaustion markers. Fas-Fas ligand coexpression indicates their high susceptibility to activation-induced cell death. Consistent therewith, FeSO4 alone induces Vδ2+ subset-specific proliferation in healthy peripheral blood mononuclear cells comparable to stimulation by ZOL, and blocking experiments identify FeSO4-induced proliferation as BTN3A1/TCR mediated. Pyrophosphate is key for Vδ2+-TCR ligand formation. Iron, by suppressing pyrophosphatase alkaline phosphatase, promotes their stability. Therefore, our data suggest that the transcriptional repression of pyrophosphatases, as under the conditions of iron overload in hemochromatosis in vivo, leads to the constitutive availability of stress-signaling Vδ2+-TCR ligand and permanent TCR triggering in Vδ2+ T cells even under homeostatic conditions, which ultimately results in their subset-specific, activation-induced cell death. A similar phenotype was observed in patients with iron overload due to inborn hemoglobinopathies, suggesting an inverted Vδ2+/Vδ2- ratio in the γδ T-cell compartment as a hallmark of iron overload.

Indexed as

HemochromatosisHemochromatosis ProteinHomeostasisIron OverloadReceptors, Antigen, T-Cell, gamma-deltaT-LymphocytesAdultAgedCell ProliferationFemaleHumansIronLymphocyte ActivationMaleMiddle AgedReactive Oxygen SpeciesHemochromatosis ProteinHFE protein, humanIronReactive Oxygen SpeciesReceptors, Antigen, T-Cell, gamma-deltaZoledronic Acid

Identifiers

PMID40163804
PMCPMC12824665

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.